remifentanil

Known as: 3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester, 1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester, Remifentanyl 
 
National Institutes of Health

Related topics

Related topics

12 relations

Broader (4)

Analgesics, OpioidAnesthetics, IntravenousHypnotics and SedativesPiperidines
Drug AllergyOpioid Agonists [MoA]PainRemifentanil hydrochloride
(More)

Narrower (2)

GI 87084BUltiva

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil.
Evidence from behavioral and self-reported data suggests that the patients' beliefs and expectations can shape both therapeutic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine.
BACKGROUND Remifentanil-induced secondary hyperalgesia has been documented experimentally in both animals and healthy human… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy.
BACKGROUND The purpose of this investigation was to describe the pharmacodynamic interaction between propofol and remifentanil… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers.
BACKGROUND Dexmedetomidine, a highly selective alpha2-adrenoceptor agonist used for short-term sedation of mechanically… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal
Numerous animal studies suggest that acute and chronic exposure to opioids can be associated with the development of hyperalgesia… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement.
BACKGROUND Rapid development of acute opioid tolerance is well established in animals and is more likely to occur with large… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The effect of remifentanil on the bispectral index change and hemodynamic responses after orotracheal intubation.
UNLABELLED In order to examine whether changes in the bispectral index (BIS) may be an adequate monitor for the analgesic… (More)
Is this relevant?
Review
1996
Review
1996
Remifentanil: a novel, short-acting, mu-opioid.
Because of remifentanil's unique pharmacokinetics, its systemic administration may be suitable for clinical settings where a… (More)
Is this relevant?
Review
1995
Review
1995
Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal.
Remifentanil is a novel, short-acting mu-receptor opioid agonist currently in the late stages of development. A member of the 4… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B).
Remifentanil is a newly synthesized 4-anilido-piperidine with an ester side chain susceptible to esterase metabolism. We… (More)
Is this relevant?